RxDoctor Payments DataLook up a doctor →

Mark Souder, MD

Family Medicine · Auburn, INNPI 1245218973

Payments from drug & device makers

$24,326in general payments, 2019–2025

Across 1,098 payments — averaging $22.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$5K
  • AstraZeneca$2K
  • GSK$2K
  • Supernus Pharmaceuticals, Inc.$1K
  • Amgen$1K
  • Lilly USA, LLC$1K
  • plus $11K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)212$5,303
AstraZeneca77$2,113
GSK60$1,603
Supernus Pharmaceuticals, Inc.74$1,438
Amgen51$1,205
Lilly USA, LLC54$1,191
Novo Nordisk34$1,042
Bayer35$909
Otsuka America Pharmaceutical, Inc.19$810
Pfizer43$778
Corium, LLC35$712
Axsome Therapeutics, Inc.20$580
Ironshore Pharmaceuticals Inc.48$580
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)20$472
Sanofi-aventis U.S. LLC23$466
Boehringer Ingelheim22$428
Tris Pharma Inc27$421
Takeda Pharmaceuticals U.S.A., Inc.21$324
Adlon Therapeutics L.p.19$277
Sunovion Pharmaceuticals Inc.18$257
Lundbeck LLC11$252
Amarin Pharma, Inc.15$245
Neurocrine Biosciences, Inc.10$193
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC7$188
Johnson & Johnson10$177
Avanir Pharmaceuticals, Inc.4$171
Novartis11$170
Jazz Pharmaceuticals Inc.7$163
Abbott6$143
E.r. Squibb & Sons, L.L.C.8$132
Acadia Pharmaceuticals Inc6$130
Nestle Healthcare Nutrition Inc.15$130
Antares Pharma, Inc.7$109
Biohaven Pharmaceutical Holding Company Ltd.2$96
Harmony Biosciences LLC4$93
Astellas Pharma US Inc5$86
Exact Sciences5$79
Kowa Pharmaceuticals America, Inc.5$76
Smith+Nephew3$68
Teva Pharmaceuticals USA, Inc.3$65
Merck5$63
Paratek Pharmaceuticals, Inc.4$58
Eisai Inc.3$51
Dexcom, Inc.3$49
Radius Health, Inc.3$47
Alkermes, Inc.2$40
Corcept Therapeutics2$33
Shire North American Group Inc2$30
Scilex Pharmaceuticals Inc.2$30
Bausch Health US, LLC2$29
Esperion Therapeutics, Inc.2$28
Watermark Medical, Inc.1$22
Collegium Pharmaceutical, Inc.1$22
Insulet Corporation1$18
Boston Scientific1$17
Neos Therapeutics, LP1$16
Sumitomo Pharma America, Inc.1$16
Halozyme Inc1$16
VBI Vaccine (delaware) Inc.1$15
Daiichi Sankyo Inc.1$13

How this compares

$24,326 in reported general payments places this provider in the 95th percentile of 2,709 family medicine providers in Indiana.

See all family medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$107,698
Medicare patients
164
Services billed
1,287

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Auburn

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →